カテゴリ： MarketLine, アメリカ, 企業調査

PG&E Corporation：企業の戦略・SWOT・財務情報

◆英語タイトル：PG&E Corporation - Strategy, SWOT and Corporate Finance Report
◆商品コード：DATA904C4333
◆発行会社（調査会社）：MarketLine
◆発行日：2018年8月
◆ページ数：50
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：アメリカ
◆産業分野：石油・ガス
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD175 ⇒換算￥25,900見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD525 ⇒換算￥77,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

PG&E Corporation – Strategy, SWOT and Corporate Finance Report
Summary

PG&E Corporation – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

PG&E Corporation (PG&E or ‘the company’) is an energy-based holding company for Pacific Gas and Electric Company (Pacific Gas and Electric). PG&E operates through two business segments: Electric and Natural Gas. PG&E’s subsidiaries provide customers with public utility services, and services relating to the generation of energy, transmission of electricity and natural gas, generation of electricity, and the distribution of energy. The company primarily operates in the US. It is headquartered in San Francisco, California.

Scope

- Detailed information on PG&E Corporation required for business and competitor intelligence needs
- A study of the major internal and external factors affecting PG&E Corporation in the form of a SWOT analysis
- An in-depth view of the business model of PG&E Corporation including a breakdown and examination of key business segments
- Intelligence on PG&E Corporation’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about PG&E Corporation, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of PG&E Corporation and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess PG&E Corporation as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on PG&E Corporation’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
PG&E Corporation: Company Overview 9
PG&E Corporation: Overview and Key Facts 9
PG&E Corporation: Overview 9
PG&E Corporation: Key Facts 9
PG&E Corporation: Key Employees 11
PG&E Corporation: Key Employee Biographies 13
PG&E Corporation: Major Products and Services 19
PG&E Corporation: Company History 20
PG&E Corporation: Management Statement 25
PG&E Corporation: Locations and Subsidiaries 28
PG&E Corporation: Key Competitors 29
PG&E Corporation: Company Analysis 30
PG&E Corporation: Business Description 30
PG&E Corporation: SWOT Analysis 32
PG&E Corporation: SWOT Overview 32
PG&E Corporation: Strengths 32
PG&E Corporation: Weaknesses 33
PG&E Corporation: Opportunities 33
PG&E Corporation: Threats 34
PG&E Corporation: Corporate Financial Deals Activity 35
PG&E Corporation: Financial Deals Overview 35
PG&E Corporation: Top Deals 2014 – 2018YTD* 37
PG&E Corporation: Advisors 38
PG&E Corporation: Top Legal Advisors 38
PG&E Corporation: Top Financial Advisors 38
PG&E Corporation: Capital Raising 39
PG&E Corporation: Recent Developments 40
PG&E Corporation: News and Events Summary 40
PG&E Corporation: Business Expansion 43
PG&E Corporation: Corporate Governance 43
PG&E Corporation: Financial Deals 44
PG&E Corporation: Financial Performance 44
PG&E Corporation: Regulatory and Legal Events 45
PG&E Corporation: Strategy and Operations 45
Appendix 48
Contact Us 48
Methodology 48
About MarketLine 49

List of Tables
Table 1: PG&E Corporation: Key Facts
Table 2: PG&E Corporation: Key Employees
Table 3: PG&E Corporation: Locations and Subsidiaries
Table 4: PG&E Corporation: Key Competitors
Table 5: PG&E Corporation: Deal Activity by Deal Type - Volume (TTM*)
Table 6: PG&E Corporation: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 7: PG&E Corporation: Top Deals 2014 - 2018YTD*
Table 8: PG&E Corporation: Legal Advisor Ranking by Value (US$m)
Table 9: PG&E Corporation: Financial Advisor Ranking by Value (US$m)
Table 10: PG&E Corporation: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Table 11: PG&E Corporation: Capital Raising by Deal Type (2014 - YTD*2018)
Table 12: PG&E Corporation: News and Events Summary
Table 13: PG&E Corporation: Business Expansion
Table 14: PG&E Corporation: Corporate Governance
Table 15: PG&E Corporation: Financial Deals
Table 16: PG&E Corporation: Financial Performance
Table 17: PG&E Corporation: Regulatory and Legal Events
Table 18: PG&E Corporation: Strategy and Operations

List of Figures
Figure 1: PG&E Corporation: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: PG&E Corporation: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 3: PG&E Corporation: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Figure 4: PG&E Corporation: Capital Raising by Deal Type (2014 - YTD*2018)

★海外企業調査レポート[PG&E Corporation：企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • MannKind Corp (MNKD)：医療機器：M&Aディール及び事業提携情報
    Summary MannKind Corp (MannKind) is a biopharmaceutical company that develops and commercializes inhaled therapeutic products for patients suffering from diabetes and pulmonary arterial hypertension. Its flagship product, Afrezza is a US FDA approved rapid-action inhaled insulin used to control high …
  • Fortune Electric Co Ltd (1519)：企業の財務・戦略的SWOT分析
    Summary Fortune Electric Co Ltd (Fortune Electric) is a power company that manufactures and markets transformers and accessories. The company's products include distribution transformers, power transformers, cast resin transformers and amorphous metal alloy core transformers, among others. It offers …
  • CareDx Inc (CDNA)-医療機器分野：企業M&A・提携分析
    Summary CareDx Inc (CareDx) formerly XDx Inc, is a commercial stage molecular diagnostics company that develops, markets, and delivers diagnostic surveillance solutions for heart transplant patients. The company offers commercialized testing solution, the AlloMap heart transplant molecular test, is …
  • Dundee Corporation：企業のM&A・事業提携・投資動向
    Dundee Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Dundee Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …
  • Ypsomed Holding AG (YPSN)：医療機器：M&Aディール及び事業提携情報
    Summary Ypsomed Holding AG (Ypsomed) is a medical device company that designs, develops and manufactures injection and infusion systems for self-medication and offers related services. It offers autoinjectors, dual chamber pens, and pen injectors. The company also offers services ranging from design …
  • ACell Inc：企業の製品パイプライン分析
    Summary ACell Inc (ACell) is a medical device company that offers products for wounds and various surgical procedures. The company develops and manufactures products to facilitate the body’s ability to repair and remodel tissue. Its products portfolio includes burn matrix products, multilayer wound …
  • Hydrogenics Corporation (HYG)-エネルギー分野：企業M&A・提携分析
    Summary Hydrogenics Corporation (Hydrogenics) is a provider of power generation equipment. It designs, develops, and manufactures hydrogen generation, energy storage, and fuel cell products. The company produces products on water electrolysis technology and proton exchange membrane (PEM) technology. …
  • TOMS Gruppen AS：企業の戦略的SWOT分析
    TOMS Gruppen AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Kenya Electricity Generating Co Ltd (KGEN)：電力：M&Aディール及び事業提携情報
    Summary Kenya Electricity Generating Co Ltd (KenGen) is an electricity generation utility. It produces power from hydro, geothermal, thermal, and wind sources. Under power purchase agreements, the company sells power to customers on wholesale basis. Kenya Power and Lighting Company Limited is the au …
  • Rigel Pharmaceuticals Inc (RIGL)：製薬・医療：M&Aディール及び事業提携情報
    Summary Rigel Pharmaceuticals Inc. (Rigel) is a biotechnology company that discovers and develops innovative small-molecule drugs for patients with immune disorders, hematological disorders, cancer and rare diseases. Its research activities focus on signaling pathways that are critical to disease me …
  • ActiveCare Inc：製薬・医療：M&Aディール及び事業提携情報
    Summary ActiveCare Inc (ActiveCare) is a medical equipment company that monitors health analytics. The company provides monitoring component to traditional disease management and wellness solutions. It offers solutions such as diabetes supplies, online web-based administrative tools, browser and iPh …
  • NOW Inc (DNOW)：企業の財務・戦略的SWOT分析
    NOW Inc (DNOW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • Seikagaku Corp (4548)：企業の財務・戦略的SWOT分析
    Summary Seikagaku Corp (Seikagaku) is a manufacturer and supplier of pharmaceuticals and medical devices. The company offers products such as pharmaceuticals and medical devices, bulk products, endotoxin-detecting reagents and oral care products. It manufactures and markets pharmaceutical products c …
  • Showa Sangyo Co., Ltd.：企業の戦略・SWOT・財務情報
    Showa Sangyo Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Showa Sangyo Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Taragenyx Ltd：製品パイプライン分析
    Summary Taragenyx Ltd (Taragenyx) is a medical technology company that offers regenerative medicine technology, medical and biological engineering solutions. The company provides restorative implant solutions generation, burdensome operations, and medical, orthopedic and dental implantation solution …
  • Banc of California, Inc.：企業のM&A・事業提携・投資動向
    Banc of California, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Banc of California, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisiti …
  • Syros Pharmaceuticals Inc (SYRS)：医療機器：M&Aディール及び事業提携情報
    Summary Syros Pharmaceuticals Inc (Syros) is a biopharmaceutical company that develops medicines for the treatment of cancer, immune-mediated diseases, and other diseases. The company’s pipeline products under clinical trials include SY-1425, an oral, potent and selective RARa agonist that is used t …
  • Astute Medical Inc-製薬・医療分野：企業M&A・提携分析
    Summary Astute Medical Inc (Astute Medical) is a healthcare service provider that provides diagnostic products. The company offers biomarker products such as nephro check test and astute meter. Its products are used in the field of identifying and validating biomarkers of acute kidney injury through …
  • Second Genome Inc：製薬・医療：M&Aディール及び事業提携情報
    Summary Second Genome Inc (Second Genome), formerly PhyloTech Inc, is a clinical stage pharmaceutical company that provides microbial research and drug discovery services. The company’s pipeline products include SGM-1019, a small molecule inhibitor targeting tissue injury and inflammation; and SG-2- …
  • Central Electricity Generating Co：企業の戦略的SWOT分析
    Central Electricity Generating Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆